Has Vladimir Gelfand received payments from drug or device companies?

Yes. Drug and device makers reported $11,422 in general payments to Vladimir Gelfand across 776 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Vladimir Gelfand did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Vladimir Gelfand come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Vladimir Gelfand

Internal Medicine · Chesterfield, MONPI 1346303641

Payments from drug & device makers

$11,422in general payments, 2019–2025

Across 776 payments — averaging $14.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
Amgen$782
Pfizer$771
Lilly USA, LLC$615
AstraZeneca$584
Novo Nordisk$487
plus $7K from 54 others

What the payments were for

Food & beverage$11,18798%
Education$2352%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	96	$1,342
Amgen(2 entities)	52	$782
Pfizer	51	$771
Lilly USA, LLC	45	$615
AstraZeneca(2 entities)	35	$584
Novo Nordisk	35	$487
Astellas Pharma US Inc	17	$447
GSK	34	$437
Novartis	31	$414
Clarus Therapeutics Inc.	17	$335
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	24	$332
Supernus Pharmaceuticals, Inc.	17	$327
Johnson & Johnson(2 entities)	20	$309
Amarin Pharma, Inc.	20	$283
Antares Pharma, Inc.	19	$253
Merck	18	$244
Eisai Inc.	23	$242
Arbor Pharmaceuticals, Inc.	23	$225
Biohaven Pharmaceutical Holding Company Ltd.	15	$212
Kowa Pharmaceuticals America, Inc.	15	$207
Esperion Therapeutics, Inc.	15	$190
Biohaven Pharmaceuticals, Inc.	12	$170
Sunovion Pharmaceuticals Inc.	10	$166
Amneal Pharmaceuticals LLC	9	$135
Avanir Pharmaceuticals, Inc.	5	$119
Takeda Pharmaceuticals U.S.A., Inc.	11	$117
Sanofi-aventis U.S. LLC	6	$114
Otsuka America Pharmaceutical, Inc.	7	$113
Teva Pharmaceuticals USA, Inc.	5	$90
Bayer	5	$82
E.r. Squibb & Sons, L.L.C.	5	$80
Adlon Therapeutics L.p.	6	$78
Aytu Biopharma, Inc.	5	$75
Lundbeck LLC	3	$70
Jazz Pharmaceuticals Inc.	5	$69
Paratek Pharmaceuticals, Inc.	4	$64
VBI Vaccine (delaware) Inc.	4	$64
Ironwood Pharmaceuticals, Inc	4	$56
Genentech USA, Inc.	3	$51
Zyla Life Sciences, Inc.	4	$49
Shield Therapeutics Inc	3	$48
Currax Pharmaceuticals LLC	3	$44
Daiichi Sankyo Inc.	2	$42
Abbott	3	$41
Mission Pharmacal Company	2	$41
Boehringer Ingelheim	3	$38
GE HealthCare	2	$36
Regeneron Healthcare Solutions, Inc.	2	$35
Biogen	2	$33
Idorsia Pharmaceuticals US Inc	2	$27
Medtronic	2	$27
Sanofi	1	$26
QOL Medical, LLC	4	$26
Corcept Therapeutics	1	$20
Neotract Inc.	1	$18
Grifols USA, LLC	1	$18
Optinose US, Inc.	1	$17
Smith+Nephew	1	$16
Shire North American Group Inc	1	$16
Gilead	1	$14

How this compares

$11,422 in reported general payments places this provider in the 95th percentile of 2,097 internal medicine providers in Missouri.

See all internal medicine providers in Missouri →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Potassium Chloride	11	$131

Paid to pharmacies, not to this prescriber.

Other internal medicine in Chesterfield

Jianbo WangChesterfield$643K
Timothy SmithSaint Peters$21.4M
Craig DietzKansas City$4M
Michael ReschakSaint Louis$3.1M
Dima DandachiColumbia$1.2M
Santosh SharmaKansas City$782K
David PrelutskySaint Louis$575K
Danish JabbarSaint Louis$510K
Dubert GuerreroIndependence$369K
Hany SalamaSaint Louis$279K

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →